{"id":5984,"date":"2024-12-13T12:49:05","date_gmt":"2024-12-13T11:49:05","guid":{"rendered":"https:\/\/pharmalundensis.se\/?p=5984"},"modified":"2024-12-13T13:19:11","modified_gmt":"2024-12-13T12:19:11","slug":"positive-patent-notice-for-phal-501","status":"publish","type":"post","link":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/","title":{"rendered":"Positive patent notice for Phal-501"},"content":{"rendered":"<p>PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is positive and states that the <strong>PCT application meets all the requirements for patenting<\/strong> (novelty, inventive step and industrial applicability). The PCT application can now form the basis for patents in a large number of countries in the world that are part of the PCT cooperation, which are most major industrial nations.<\/p>\n<p><strong>CEO Staffan Skogvall<\/strong>: \u201cThe PCT review confirms that our substances are novel and patentable, which opens up the possibility of large revenues. When clinical studies confirm a good effect on COPD\/chronic bronchitis and some other diseases, Phal-501 will have a very high value.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is [&hellip;]<\/p>\n","protected":false},"author":70,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-5984","post","type-post","status-publish","format-standard","hentry","category-uncategorized-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Positive patent notice for Phal-501 - Pharmalundensis<\/title>\n<meta name=\"description\" content=\"PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is positive\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positive patent notice for Phal-501 - Pharmalundensis\" \/>\n<meta property=\"og:description\" content=\"PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is positive\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharmalundensis\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-13T11:49:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-13T12:19:11+00:00\" \/>\n<meta name=\"author\" content=\"staffan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"staffan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/\"},\"author\":{\"name\":\"staffan\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/person\\\/c9d3434afcbe17a34ed68b88c5e849e2\"},\"headline\":\"Positive patent notice for Phal-501\",\"datePublished\":\"2024-12-13T11:49:05+00:00\",\"dateModified\":\"2024-12-13T12:19:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/\"},\"wordCount\":121,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/\",\"url\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/\",\"name\":\"Positive patent notice for Phal-501 - Pharmalundensis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#website\"},\"datePublished\":\"2024-12-13T11:49:05+00:00\",\"dateModified\":\"2024-12-13T12:19:11+00:00\",\"description\":\"PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is positive\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/positive-patent-notice-for-phal-501\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/pharmalundensis.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Positive patent notice for Phal-501\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#website\",\"url\":\"https:\\\/\\\/pharmalundensis.se\\\/\",\"name\":\"Pharmalundensis\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharmalundensis.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#organization\",\"name\":\"Pharmalundensis\",\"url\":\"https:\\\/\\\/pharmalundensis.se\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharmalundensis\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharmalundensis.se\\\/#\\\/schema\\\/person\\\/c9d3434afcbe17a34ed68b88c5e849e2\",\"name\":\"staffan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g\",\"caption\":\"staffan\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Positive patent notice for Phal-501 - Pharmalundensis","description":"PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is positive","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/","og_locale":"en_US","og_type":"article","og_title":"Positive patent notice for Phal-501 - Pharmalundensis","og_description":"PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is positive","og_url":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/","og_site_name":"Pharmalundensis","article_published_time":"2024-12-13T11:49:05+00:00","article_modified_time":"2024-12-13T12:19:11+00:00","author":"staffan","twitter_card":"summary_large_image","twitter_misc":{"Written by":"staffan","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/#article","isPartOf":{"@id":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/"},"author":{"name":"staffan","@id":"https:\/\/pharmalundensis.se\/#\/schema\/person\/c9d3434afcbe17a34ed68b88c5e849e2"},"headline":"Positive patent notice for Phal-501","datePublished":"2024-12-13T11:49:05+00:00","dateModified":"2024-12-13T12:19:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/"},"wordCount":121,"commentCount":0,"publisher":{"@id":"https:\/\/pharmalundensis.se\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/","url":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/","name":"Positive patent notice for Phal-501 - Pharmalundensis","isPartOf":{"@id":"https:\/\/pharmalundensis.se\/#website"},"datePublished":"2024-12-13T11:49:05+00:00","dateModified":"2024-12-13T12:19:11+00:00","description":"PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is positive","breadcrumb":{"@id":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharmalundensis.se\/en\/positive-patent-notice-for-phal-501\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/pharmalundensis.se\/en\/"},{"@type":"ListItem","position":2,"name":"Positive patent notice for Phal-501"}]},{"@type":"WebSite","@id":"https:\/\/pharmalundensis.se\/#website","url":"https:\/\/pharmalundensis.se\/","name":"Pharmalundensis","description":"","publisher":{"@id":"https:\/\/pharmalundensis.se\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmalundensis.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharmalundensis.se\/#organization","name":"Pharmalundensis","url":"https:\/\/pharmalundensis.se\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmalundensis.se\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharmalundensis"},"image":{"@id":"https:\/\/pharmalundensis.se\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharmalundensis.se\/#\/schema\/person\/c9d3434afcbe17a34ed68b88c5e849e2","name":"staffan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6410d9a147ae7a88f9017675b041584ae6f4c52608381c8ecbf7671fbf4fde26?s=96&d=mm&r=g","caption":"staffan"}}]}},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"staffan","author_link":"https:\/\/pharmalundensis.se\/en\/author\/staffan\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/pharmalundensis.se\/en\/category\/uncategorized-en\/\" rel=\"category tag\">Uncategorized<\/a>","rttpg_excerpt":"PharmaLundensis has now received a review report from the PCT authority regarding the company\u2019s mercury-binding substance Phal-501. The report is [&hellip;]","_links":{"self":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/posts\/5984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/users\/70"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/comments?post=5984"}],"version-history":[{"count":0,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/posts\/5984\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/media?parent=5984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/categories?post=5984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmalundensis.se\/en\/wp-json\/wp\/v2\/tags?post=5984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}